Medicare Enrolled
Dr. Anirudha Dasgupta, MD
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dasgupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dasgupta? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dasgupta
Dr. Anirudha Dasgupta is a hematology & oncology in Kingwood, TX, with 20 years in practice. Based on federal Medicare data, Dr. Dasgupta performed 69,036 Medicare services across 928 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dasgupta received a total of $47,189 from 102 pharmaceutical and/or device companies across 1129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dasgupta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in TX$ $47,189 industry payments
Medicare Practice Summary
Medicare Utilization ↗69,036
Medicare services
Top 13% in TX for hematology & oncology
928
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,452 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 40,500 | $1 | $3 |
| Iron sucrose injection (Venofer) | 10,800 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia | 7,470 | $2 | $8 |
| Contrast dye for imaging (iodine-based) | 3,500 | $0 | $0 |
| MRI contrast dye injection (gadoterate) | 2,400 | $0 | $0 |
| Dexamethasone injection (steroid) | 910 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 712 | $0 | $0 |
| Office visit, established patient (30-39 min) | 487 | $93 | $346 |
| Flow cytometry, additional marker | 328 | $18 | $63 |
| Drug injection, under skin or into muscle | 314 | $11 | $38 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 304 | $22 | $82 |
| Office visit, established patient (20-29 min) | 251 | $63 | $243 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 164 | $49 | $179 |
| Administration of chemotherapy into vein, 1 hour or less | 159 | $98 | $374 |
| Irrigation of implanted venous access drug delivery device | 129 | $17 | $73 |
| Hospital follow-up visit, moderate complexity | 93 | $61 | $185 |
| Administration of chemotherapy into vein, each additional hour | 77 | $22 | $80 |
| Infusion, normal saline solution , 1000 cc | 57 | $2 | $7 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 54 | $1,160 | $5,368 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 49 | $110 | $295 |
| Injection, diphenhydramine hcl, up to 50 mg | 49 | $1 | $3 |
| New patient office visit (45-59 min) | 43 | $118 | $449 |
| Infusion into a vein for hydration, 31-60 minutes | 42 | $25 | $92 |
| Initial hospital admission, moderate complexity | 39 | $91 | $349 |
| Ct scan of chest with contrast | 28 | $57 | $425 |
| Office visit, established patient, complex (40-54 min) | 21 | $135 | $483 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $18 | $62 |
| Flow cytometry technique for dna or cell analysis, first marker | 14 | $60 | $192 |
| Initial hospital admission, high complexity | 13 | $125 | $513 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $124 | $478 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
59.5% high complexity
38.4% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,189
Total received (2018-2024)
Avg $6,741/year across 7 years
Top 13% in TX for hematology & oncology
102
Companies
1,129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,928 (71.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,011 (14.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,250 (13.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$17,737
2023$2,869
2022$5,203
2021$6,851
2020$4,858
2019$6,634
2018$3,036
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Karyopharm Therapeutics Inc.
$13,567
AstraZeneca Pharmaceuticals LP
$4,897
PFIZER INC.
$2,957
ARRAY BIOPHARMA INC
$2,015
Bayer HealthCare Pharmaceuticals Inc.
$1,938
MorphoSys, US Inc.
$1,852
Exelixis Inc.
$1,808
E.R. Squibb & Sons, L.L.C.
$1,617
Novartis Pharmaceuticals Corporation
$1,461
Amgen Inc.
$1,215
GlaxoSmithKline, LLC.
$943
Celgene Corporation
$883
Merck Sharp & Dohme Corporation
$844
Daiichi Sankyo Inc.
$580
Takeda Pharmaceuticals U.S.A., Inc.
$556
GENZYME CORPORATION
$521
Janssen Biotech, Inc.
$519
Lilly USA, LLC
$490
Gilead Sciences, Inc.
$465
Genentech USA, Inc.
$444
Seagen Inc.
$371
Boehringer Ingelheim Pharmaceuticals, Inc.
$358
Incyte Corporation
$309
Astellas Pharma US Inc
$307
EISAI INC.
$306
Eisai Inc.
$262
Merck Sharp & Dohme LLC
$255
Taiho Oncology, Inc.
$250
Rigel Pharmaceuticals, Inc.
$247
SOBI, INC
$246
BeiGene USA, Inc.
$224
Regeneron Healthcare Solutions, Inc.
$199
Alexion Pharmaceuticals, Inc.
$195
AVEO Pharmaceuticals, Inc.
$181
Ipsen Biopharmaceuticals, Inc
$177
Pharmacyclics LLC, An AbbVie Company
$157
TerSera Therapeutics LLC
$154
Dova Pharmaceuticals
$142
Janssen Pharmaceuticals, Inc
$139
CTI BioPharma Corp.
$130
Deciphera Pharmaceuticals Inc.
$130
Puma Biotechnology, Inc.
$127
ABBVIE INC.
$107
JAZZ PHARMACEUTICALS INC.
$105
TAIHO ONCOLOGY, INC.
$102
Agios Pharmaceuticals, Inc.
$95
Tempus AI, Inc
$87
SpringWorks Therapeutics, Inc.
$87
SANOFI-AVENTIS U.S. LLC
$86
Iovance Biotherapeutics, Inc.
$83
Foundation Medicine, Inc.
$81
Boston Scientific Corporation
$80
Blueprint Medicines Corporation
$77
Myovant Sciences Inc.
$75
AbbVie Inc.
$69
PUMA BIOTECHNOLOGY, INC.
$69
TESARO, Inc.
$69
Teva Pharmaceuticals USA, Inc.
$68
Sirtex Medical Inc
$65
Kyowa Kirin, Inc.
$59
EMD Serono, Inc.
$58
Sobi, Inc
$57
Seattle Genetics, Inc.
$57
Kite Pharma, Inc.
$52
PharmaEssentia USA Corporation
$50
Octapharma USA, Inc.
$46
Jazz Pharmaceuticals Inc.
$46
Adaptive Biotechnologies Corporation
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
Stemline Therapeutics Inc.
$44
Dendreon Pharmaceuticals LLC
$42
Alnylam Pharmaceuticals Inc.
$41
Acceleron Pharma, Inc.
$41
BOSTON SCIENTIFIC CORPORATION
$40
Mirati Therapeutics, Inc.
$40
Apellis Pharmaceuticals, Inc.
$36
Pharmacosmos Therapeutics Inc.
$36
Verastem, Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$29
Immunocore Limited
$29
AMAG Pharmaceuticals, Inc.
$27
Blue Earth Diagnostics Limited
$26
Inari Medical, Inc.
$26
Allergan Inc.
$24
Nestle HealthCare Nutrition Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
MEDIVATION FIELD SOLUTIONS LLC
$22
Abbott Laboratories
$21
R-Pharm US LLC
$21
Pharmacyclics LLC, an AbbVie Company
$20
ADC Therapeutics America, Inc.
$19
G1 Therapeutics, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Secura Bio, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Servier Pharmaceuticals LLC
$15
Array BioPharma Inc.
$15
Clovis Oncology, Inc.
$15
Sun Pharmaceutical Industries Inc.
$14
Sumitomo Pharma America, Inc.
$14
Genentech, Inc.
$13
Heron Therapeutics, Inc.
$12
Top 3 companies account for 45.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · Axumin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARDIOMEMS · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · Crysvita · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · Enhertu · Erleada · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Orserdu · PADCEV · PANZYGA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · S · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEFLARO · THERASPHERE · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Truxima · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $68 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
41
Per 100K population
0.9
County median income
$73,104
Nearest hospital
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dasgupta is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (low-engagement, top 13%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dasgupta experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dasgupta performed 40,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dasgupta receive payments from pharmaceutical companies?
Yes. Dr. Dasgupta received a total of $47,189 from 102 companies across 1,129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dasgupta's costs compare to other hematology & oncologys in Kingwood?
Dr. Dasgupta's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dasgupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Kingwood
Browse hematology & oncologys in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology